D
DLH Holdings Corp. DLHC
$5.76 -$0.23-3.84% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

DLH Holdings Corp. (DLHC) is a U.S.-based government services provider specializing in health, science, and national security solutions. The company operates primarily in the government contracting and healthcare services industries, delivering research, program management, systems engineering, and data analytics services to federal agencies. DLH’s core customers are U.S. government entities, with a strong concentration in civilian health agencies and defense-related organizations.

The company’s primary revenue drivers are professional and technical services supporting public health research, clinical trials, health IT modernization, and defense readiness. DLH is positioned as a mid-tier contractor with specialized expertise in complex, mission-critical programs, particularly within health and human services. Founded in 1969, DLH has evolved from a small professional services firm into a scaled federal contractor through organic growth and targeted acquisitions focused on health science and IT capabilities.

Business Operations

DLH operates as a single reportable segment but organizes its business around integrated service offerings spanning healthcare delivery support, public health research, digital modernization, and defense and security services. Revenue is generated almost entirely through long-term contracts with U.S. federal agencies, primarily on a cost-plus, time-and-materials, or fixed-price basis. The company’s operations are largely domestic, with substantially all revenue derived from U.S. government customers.

Key operating subsidiaries include DLH Solutions, Social & Scientific Systems, and GRSi, which collectively provide clinical research support, epidemiology and biostatistics, health IT systems, cybersecurity, and systems engineering services. DLH controls proprietary processes, specialized data management platforms, and a cleared professional workforce that supports classified and unclassified government programs. The company maintains contract relationships with agencies such as the Department of Health and Human Services, National Institutes of Health, Department of Defense, Department of Veterans Affairs, and the Centers for Disease Control and Prevention.

Strategic Position & Investments

DLH’s strategic direction emphasizes expansion in high-growth federal spending areas, including public health preparedness, digital health modernization, cybersecurity, and defense health services. Growth initiatives have focused on cross-selling capabilities across agencies and increasing contract scale and duration within existing customer relationships. The company has prioritized contract recompetes and task order wins to sustain backlog and revenue visibility.

Major acquisitions have played a central role in DLH’s strategy, most notably the acquisitions of GRSi and Social & Scientific Systems, which significantly expanded the company’s health IT, cybersecurity, and clinical research capabilities. These investments strengthened DLH’s positioning in data-driven health science and defense support services. While DLH continues to monitor emerging technologies such as advanced analytics and digital health platforms, publicly available sources indicate no material commercial investments outside its core federal services focus.

Geographic Footprint

DLH is headquartered in Bethesda, Maryland, and operates primarily across the United States, with personnel deployed at customer sites and government facilities nationwide. Its geographic footprint closely mirrors the distribution of U.S. federal agencies, with a strong presence in the Mid-Atlantic region, including Washington, D.C., Maryland, and Virginia.

International operations are limited and generally tied to U.S. government-funded programs conducted abroad. Based on available public disclosures, DLH does not maintain significant standalone foreign subsidiaries or material revenue streams from non-U.S. governments. The company’s international exposure is therefore considered ancillary to its domestic federal contracting base.

Leadership & Governance

DLH is led by an executive team with extensive experience in government contracting, healthcare services, and federal program management. Leadership emphasizes disciplined execution, contract performance excellence, and strategic growth through both organic initiatives and acquisitions aligned with federal mission priorities.

Key executives include:

  • Zachary C. Parker – President and Chief Executive Officer
  • John Heller – Chief Financial Officer

The company’s governance framework is aligned with public company standards, with oversight provided by an independent board of directors. Management’s stated strategic vision centers on supporting critical government missions while delivering sustainable growth and shareholder value through operational discipline and targeted investment.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $183.22
B
AAPL NASDAQ $252.82
B
MSFT NASDAQ $399.95
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $125.99
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.16
B
V NYSE $310.11
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.54
Top Health Care Stocks
See All »
B
LLY NYSE $989.12
B
JNJ NYSE $243.19
B
AMGN NASDAQ $366.25
Top Real Estate Stocks
See All »
B
PLD NYSE $133.00